Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenqi Gankang
- Development stage
- Unknown
- Administration
- Oral
01
Overview
Shenqi Gankang (参芪肝康) is a traditional Chinese medicine formulation used primarily for liver protection and the treatment of chronic liver diseases. It is commonly administered as tablets and often used in combination with antiviral therapy, particularly after transcatheter arterial chemoembolization in patients with hepatitis B virus-related conditions. The formulation is believed to exert hepatoprotective effects, potentially by modulating immune responses, reducing inflammation, and inhibiting hepatic fibrosis. Its mechanism of action involves multiple herbal components that may act synergistically to support liver function and mitigate damage from viral or toxic insults[1].
- Brand names
- Shenqi Gankang
- Other names
- 参芪肝康
Beyond the preview
Go deeper on Shenqi Gankang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenqi Gankang.